Is ASBP a buy or a trap? We analyze the ASBP gap-up, uncovering how the imminent 40:1 reverse split and toxic convertible debt incentives are creating a "fader" setup. Learn why debt holders are incentivized to short the stock and what the $0.08 floor means for traders.
$VYNE is running on a merger announcement. We analyze the 8-K valuation and dividend details to calculate the $0.74 per share baseline.
MTC was scheduled for suspension on November 5th but keeps trading—which means the company filed an appeal (even without announcing it), pushing the hearing 30-45 days out and eliminating immediate delisting risk. ⏰ [Watch the full timeline breakdown] explaining why shorts waiting for this catalyst just got their timeline extended significantly.
BYND's chart is following GME's May 2024 playbook almost perfectly—big move, gap, consolidation, fade—and now BYND just released preliminary results exactly like GME did before filing their S-3 ASR, which triggered another leg down. 📉 [Watch the pattern comparison] showing why the technical and fundamental match suggests potential financing announcements could be the next catalyst.
Beyond Meat ($BYND) has ripped over 350% in a week on Walmart expansion news and meme-stock momentum — but under the surface, a massive debt-for-equity swap and upcoming shareholder vote could reshape its entire capital structure. Here’s what’s really driving the move, what to watch ahead of earnings, and why dilution risk isn’t off the table just yet.
GSIT surged after Cornell researchers validated its Gemini-I chip matches Nvidia A6000 performance while using 98% less energy—but here's the difference from its 2023 speculative run: this time there's actual third-party proof, not just hype. 📊 [Read the full analysis] of what's changed, the Oct 30 earnings setup, and whether validation translates into commercial traction.
Research QNRX's private placement investors using Deals Screener. Track ADAR1's performance history and extract key terms from financing deals.
BTTC ripped hundreds of percent post-merger, but here's the critical detail: only 669k of 7.39M shares are actually tradable—explaining the extreme volatility—while $6M in PIPE preferred shares convertible at 85% VWAP create significant dilution overhang ahead. 📊 [Read the complete breakdown] of the float dynamics, resale restrictions, and what to watch for as shares unlock in phases.
Need to track specific clauses like "right of first refusal" or custom underwriter fee structures that standard data feeds miss? Custom data extraction services use AI to pull exactly what you need from SEC filings—both historical and ongoing—then integrate it into screenable, filterable dashboards alongside your existing datasets. 📊 [See how custom extraction works] and discover how to turn specialized research requirements into systematic advantages.
Learn to anticipate dilution in crypto treasury stocks using WKSI thresholds and filing patterns. BMNR case study shows predictable timing signals.
**How ATNF and CGTX followed their fade patterns perfectly while BSLK completely broke character—and why the "failed" BSLK setup actually taught the most valuable lesson about recognizing when historical patterns no longer apply.** 📺 [Read the full analysis] on using past behavior to guide entries and exits.
BMNR is the latest crypto treasury runner. But these moves aren’t just about news—they’re about volume, theme hype, and dilution. Here’s how I navigate them.
Sometimes the strongest signal is what doesn't happen. In this case, SRM never showed signs of selling—despite a 10x move over cost basis. Here's what I learned.
Most traders focus on dilution, but it's often the catalyst—like a reset or inducement—that drives the move. Here's how to spot them before they trigger.
AlphaSense is built for enterprise users. AskEdgar offers a leaner, AI-powered alternative for traders and analysts who focus on filings, transcripts, and press releases.
EdmundSEC provides easy access to SEC filings with AI-powered summaries. Here’s how it stacks up next to AskEdgar’s multi-document analysis and risk tools.
FlashSEC is an automated platform for dilution and filing research. Here's how it compares to AskEdgar’s AI-driven approach to SEC analysis and small-cap risk.
Dilution Tracker pioneered dilution monitoring tools for small-cap stocks. Here's a look at its capabilities and how platforms like AskEdgar take a broader AI-based approach.
CapEdge is a free SEC research tool that offers ownership data, filing comparison, and search alerts. Here's how it compares to AI-driven alternatives like AskEdgar.
BamSEC is a go-to platform for reading SEC filings and earnings transcripts. Here's how it stacks up and where platforms like AskEdgar take a different approach.